Retatrutide 20mg Vial
£90.00
Storage Instructions
Store in a cool, dry place away from direct sunlight. Once reconstituted, refrigerate at 2–8°C.
Description
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This triagonist architecture represents a distinct pharmacological approach in metabolic signalling research, engaging three incretin-related receptor pathways in preclinical models.
Research Context
Preclinical studies have examined Retatrutide's binding profiles across GIP, GLP-1, and glucagon receptors, investigating downstream signalling cascades and their interactions in metabolic pathway research. Supplied exclusively for in vitro laboratory research purposes.
Related Products
This product is supplied for in-vitro laboratory research only. Not for human consumption, medical treatment, or cosmetic use.
Disclaimer for 31-32 Peptides Purchase
By purchasing from 31-32 Peptides, you acknowledge and agree that:
- Research Use Only: All products are exclusively sold for research purposes. They are not intended for human use, therapeutic, diagnostic, or clinical application.
- Not Medical Products: None of the products listed on our website are medical products, nor should they be marketed or used as such.
- Compliance and Responsibility: The buyer is responsible for ensuring compliance with all relevant laws and regulations. 31-32 Peptides holds no liability for misuse of products or any adverse outcomes.
Your purchase signifies your understanding and agreement to these terms.